These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 18476587)
1. [Prevention and treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation for acute leukemias]. Da WM; Wu T; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):793-4. PubMed ID: 18476587 [No Abstract] [Full Text] [Related]
2. [Relapse of acute leukemia after allogeneic stem cell transplantation: its mechanisms and strategies for the prevention and treatment]. Wang JM Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):649-50. PubMed ID: 23978012 [No Abstract] [Full Text] [Related]
3. Chimerism-directed adoptive immunotherapy in prevention and treatment of post-transplant relapse of leukemia in childhood. Formánková R; Sedlácek P; Krsková L; Ríhová H; Srámková L; Star J; Haematologica; 2003 Jan; 88(1):117-8. PubMed ID: 12551838 [No Abstract] [Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation after surgical resection of pulmonary aspergillosis in 5 patients with acute leukemia. Motohashi K; Ito S; Hagihara M; Sakai R; Tanaka M; Kawano T; Maruta A; Ishigatsubo Y; Kanamori H Rinsho Ketsueki; 2009 May; 50(5):430-4. PubMed ID: 19483405 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994 [TBL] [Abstract][Full Text] [Related]
6. [Prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation]. Liu C; Liu QF Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):729-32. PubMed ID: 23978031 [No Abstract] [Full Text] [Related]
7. Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years. Giebel S; Labopin M; Holowiecki J; Labar B; Komarnicki M; Koza V; Masszi T; Mistrik M; Lange A; Hellmann A; Vitek A; Pretnar J; Mayer J; Rzepecki P; Indrak K; Wiktor-Jedrzejczak W; Wojnar J; Krawczyk-Kulis M; Kyrcz-Krzemien S; Rocha V Ann Hematol; 2009 Oct; 88(10):1005-13. PubMed ID: 19301005 [TBL] [Abstract][Full Text] [Related]
8. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355 [TBL] [Abstract][Full Text] [Related]
9. [Physiopathology and possible clinical use of hematopoietic stem cells. Recent advances]. Testa U Recenti Prog Med; 2009 Mar; 100(3):144-55. PubMed ID: 19475843 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Pulsipher MA; Bader P; Klingebiel T; Cooper LJ Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):62-71. PubMed ID: 19147081 [TBL] [Abstract][Full Text] [Related]
11. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686 [TBL] [Abstract][Full Text] [Related]
12. [Relapse in acute promyelocytic leukemia and the role of hematopoietic stem cell transplantation in the treatment of APL]. Zák P; Korístek Z Vnitr Lek; 2008; 54(7-8):751-6. PubMed ID: 18780574 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality. Meijer E; Cornelissen JJ Semin Oncol; 2008 Aug; 35(4):449-57. PubMed ID: 18692695 [TBL] [Abstract][Full Text] [Related]
14. Controversies of and unique issues in hematopoietic cell transplantation for infant leukemia. Hunger SP; Loh KM; Baker KS; Schultz KR Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):79-83. PubMed ID: 19147083 [TBL] [Abstract][Full Text] [Related]
15. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation. Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173 [TBL] [Abstract][Full Text] [Related]
16. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation. Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024 [TBL] [Abstract][Full Text] [Related]
17. The influence of infection early after allogeneic stem cell transplantation on the risk of leukemic relapse and graft-versus-host disease. Kim SY; Lee DG; Kim MS; Kim HJ; Lee S; Min CK Am J Hematol; 2008 Oct; 83(10):784-8. PubMed ID: 18661492 [TBL] [Abstract][Full Text] [Related]
18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia. Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296 [TBL] [Abstract][Full Text] [Related]
19. Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors. Sedlacek P; Mejstrikova E; Formankova R; Keslova P; Dobrovolna M; Vrana M; Stary J Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S10-5. PubMed ID: 18978735 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute leukemia with allogeneic stem cell transplantation]. Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]